Autor segons l'article: Siqueira J; Sutton D; García D; Gené J; Thomson P; Wiederhold N; Guarro J
Departament: Ciències Mèdiques Bàsiques
Autor/s de la URV: García Sánchez, Dania / Gené Díaz, Josepa / Guarro Artigas, Josep / ZEN SIQUEIRA, JOAO PAULO
Paraules clau: Taxonomy Sydowii Penicillium Onychomycosis Multilocus phylogeny Metabolites Infection Identification Endolichenic fungus Aspergilli Ascomycetes Antufungal activity Amphotericin-b Agents multilocus phylogeny aspergilli ascomycetes antufungal activity
Resum: © 2016 British Mycological Society Aspergillus section Versicolores includes species of clinical relevance and many others that have been poorly studied but are occasionally found in clinical samples. The aim of this study was to investigate, using a multilocus phylogenetic approach, the spectrum of species of the section Versicolores and to determine their in vitro antifungal susceptibility. The study was based on a set of 77 clinical isolates from different USA medical centres, which had been previously identified as belonging to this section. The genetic markers used were internal transcribed spacer (ITS), β-tubulin (BenA), calmodulin (CaM), and RNA polymerase II second largest subunit (RPB2), and the drugs tested, following the CLSI guidelines, were amphotericin B (AMB), itraconazole, posaconazole, voriconazole, anidulafungin, caspofungin, micafungin, terbinafine (TBF), and flucytosine (5FC). The most frequent species were Aspergillus sydowii (26 %), Aspergillus creber (22 %), and Aspergillus amoenus (18.2 %), followed by Aspergillus protuberus (13 %), Aspergillus jensenii (10.4 %), and Aspergillus tabacinus (5.2 %); while Aspergillus cvjetkovicii, Aspergillus fructus, Aspergillus puulaauensis, and Aspergillus versicolor were represented by only one isolate each (1.3 %). This is the first time that A. jensenii and A. puulaauensis have been reported from clinical samples. Considering the high number of isolates identified as belonging to this fungal group in this study, its clinical relevance should not be overlooked. Aspergillus versicolor, traditionally considered one of the most common species in this section in a clinical setting, was only rarely recovered in our study. The in vitro antifungal results showed that echinocandins and TBF were the most potent drugs, the azoles showed variable results, AMB was poorly active, and 5FC was the less active.
Grup de recerca: Unitat de Micologia i Microbiologia Ambiental
Àrees temàtiques: Zootecnia / recursos pesqueiros Química Plant science Mycology Medicina veterinaria Medicina ii Medicina i Interdisciplinar Infectious diseases Genetics Farmacia Engenharias iv Economia Ecology, evolution, behavior and systematics Ciências biológicas iii Ciências biológicas ii Ciências biológicas i Ciências ambientais Ciências agrárias i Ciência de alimentos Biotecnología Biodiversidade
Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
ISSN: 18786146
Adreça de correu electrònic de l'autor: dania.garcias@urv.cat josepa.gene@urv.cat
Identificador de l'autor: 0000-0003-2397-1646 0000-0001-6195-9299
Data d'alta del registre: 2024-09-07
Versió de l'article dipositat: info:eu-repo/semantics/acceptedVersion
Enllaç font original: https://www.sciencedirect.com/science/article/pii/S187861461600043X?via%3Dihub
URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
Referència a l'article segons font original: Fungal Biology. 120 (11): 1458-1467
Referència de l'ítem segons les normes APA: Siqueira J; Sutton D; García D; Gené J; Thomson P; Wiederhold N; Guarro J (2016). Species diversity of Aspergillus section Versicolores in clinical samples and antifungal susceptibility. Fungal Biology, 120(11), 1458-1467. DOI: 10.1016/j.funbio.2016.02.006
DOI de l'article: 10.1016/j.funbio.2016.02.006
Entitat: Universitat Rovira i Virgili
Any de publicació de la revista: 2016
Tipus de publicació: Journal Publications
Repositori URV